Loading clinical trials...
Loading clinical trials...
The purpose of this study is to investigate new therapies for advanced lung disease.
This research study is being conducted to learn about the progression and cause of lung disease. By agreeing to be a part of this study, you will allow the lung tissue which would normally have been discarded after your procedure, to be used for research purposes to allow us to understand more about your condition which may potentially lead to novel treatments and therapeutics. For this study, the investigators will isolate specific cells from the lung tissue and measure cellular, molecular and genetic mechanisms responsible for regulating lung disease. No other type of research will be performed on these samples nor will the samples be given to other investigators for unrelated research.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Davis Heart and Lung Research Institute
Columbus, Ohio, United States
Start Date
February 1, 2015
Primary Completion Date
July 1, 2025
Completion Date
July 1, 2025
Last Updated
July 29, 2025
novel biomarkers of lung disease
OTHER
Lead Sponsor
Ohio State University
NCT04707781
NCT06122233
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05722340